Tandem Diabetes CareUnderstanding Coverage for Pumps & Supplies
Managing diabetes is demanding enough without worrying about high monthly costs. Most Tandem pump users pay less than $50 per month, and more than 30% pay $0 out of pocket, including essential supplies like cartridges and infusion sets.1 Find out what your plan may cover.
Now available via pharmacy benefits
Our pumps with Control-IQ+ technology adjust insulin delivery automatically to help you manage your diabetes. With expanded coverage that now includes pharmacy benefits, getting started is easier and more affordable than ever.
Broad Coverage
We’ve expanded coverage to help you access Tandem products, with preferred placement through your pharmacy benefits, medical benefits, or Medicare Part B.
Check Your Benefits
You can depend on our Customer Care team for individualized guidance and support. Available 24 hours a day and 7 days a week at (877) 801-6901.
How it Works
We’ll contact your provider and insurer to verify benefits and secure the lowest out-of-pocket cost. Then we’ll guide you through ordering and provide status updates.
Frequently Asked Questions
A Tandem Pump Specialist will check your insurance coverage and help you get started.
* For more information on the monthly payment plan, please see tandemdiabetes.com/support/benefit-programs/payment-plan.
References
1. $50 monthly claim: Cost per month calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month. $0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.